MHLW Warns Of Of Higher Risk Of Aggressive Behavior In Patients On Antidepressants
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare June 24 called attention to SSRI and SNRI antidepressants. The ministry cited a higher risk of aggressive behaviors towards others and required physicians to use caution when prescriptions. The SSRI drugs currently available in Japan include Paxil (paroxetine), Luvox (fluvoxamine), Depromel (fluvoxamine) and Zoloft (sertraline). The most prescribed drug is Paxil with estimated annual prescriptions of 1.23 million. (Click here for more - Japanese language